IMMUNISATION AGAINST SEROGROUP B MENINGOCOCCAL DISEASE - HOPES AND FEARS
PANEL DISCUSSION MODERATED BY PROF PAUL HEATH
PANELISTS: PROF ADAM FINN, UNIVERSITY OF BRISTOL, DR SIMON NADEL, PROF ROBERT READ, DR MATTHEW SNAPE AND DR CAROLINE TROTTER
Paul Heath is a Professor / Honorary Consultant in Paediatric Infectious Diseases at St George’s, University of London and Vaccine Institute in London. His training in paediatrics and infectious diseases was at the Royal Children’s Hospital, Melbourne, the John Radcliffe Hospital, Oxford and St George’s Hospital, London. His particular research interests are in the epidemiology of vaccine preventable diseases, in clinical vaccine trials, particularly in at-risk groups, and in perinatal infections.
He coordinates a national neonatal infection surveillance network (neonIN) and recently, a national study on neonatal meningitis. He sits on national committees concerned with meningitis, Group B streptococcus prevention, pneumococcal and Hib infections, neonatal infections and on immunisation policies in children. He is a Fellow of the Royal Australasian College of Physicians, a Fellow of the Royal College of Paediatrics and Child Health, a member of the research committee of the European Society of Paediatric Infectious Diseases and a member of the steering committee of the international Brighton Collaboration on vaccine safety.
Adam Finn is Professor of Paediatrics and a member of the Schools of Clinical Sciences and of Cellular and Molecular Medicine at the University of Bristol and an honorary Consultant in Paediatric Infectious Diseases and Immunology at Bristol Royal Hospital for Children. He is director of the South West Medicines for Children Research Network and heads the Bristol Children’s Vaccine Centre. He trained in Infectious Diseases at the Children’s Hospital of Philadelphia and in Immunology at the Institute of Child Health in London where he obtained his PhD.
He worked in Sheffield between 1992 and 2001 where he was involved in several trials of meningococcal group C and other vaccines. His current main research interest is the biology of respiratory infections and how vaccines affect transmission of infections.
Simon Nadel has been a Consultant in Paediatric Intensive Care since 1994. Prior to this he trained in paediatric infectious diseases. He has been involved in coordinating and running therapeutic trials in children with meningococcal and other septic shock, and has taken part in research studies into the pathophysiology, treatment and outcome of meningococcal disease in children. He has been involved in writing clinical guidelines for the management of children with septicaemia and meningitis.
Professor Robert Read undertook clinical and research training in Leeds, Bristol, London, Nottingham and San Francisco. He was appointed as an academic infectious disease physician
at the University of Sheffield in 1995 and served as Professor of Infectious Diseases there from 2002-2012, prior to moving to Southampton in September 2012.
Professor Read has research interests in the pathogenesis and prevention of rapidly lethal infectious diseases, especially meningococcal and pneumococcal disease, and influenza.
He is the chairman of the Infectious Diseases and Microbiology Speciality Group for the NIHR clinical research network, and chairs the postdoctoral awards panel for the NIHR Personal Training Fellowships scheme. He is the current chairman of the Annual Meeting Program Committee of the Infectious Disease Society of America.
He is Editor in Chief of the Journal of Infection and Current Opinion in Infectious Diseases, and is author and co-author of 200 publications mainly in the field of infectious diseases. He was appointed as a member
of the UK’s Joint Committee on Vaccination and Immunisation (JCVI) in September 2013
Dr Matthew Snape is a consultant in General Paediatrics and Vaccinology at the Oxford University Hospitals NHS trust and an Honorary Senior Clinical Lecturer at the University of Oxford.
After completing basic training in paediatrics at the Royal Children’s Hospital, Melbourne, he spent 18 months working in the paediatric intensive care unit at St Mary’s Hospital, London. While caring for children suffering overwhelming infections he developed an interest in the prevention of these illnesses by immunisation. This led him to the Oxford Vaccine Group, University of Oxford, where he has been the principal investigator on paediatric studies of meningococcal, pneumococcal, influenza and Hepatitis B vaccines.
Dr Snape is partially funded by the Oxford Partnership Comprehensive Biomedical Research Centre.
Dr Caroline Trotter is an infectious disease epidemiologist at the University of Cambridge. Her research focuses on assessing the potential and actual impact of vaccination against different forms of bacterial meningitis on a population level. She uses a range of research methods including mathematical modelling, cost- effectiveness analyses, carriage studies, analyses of large databases and seroprevalence studies. She is currently working with the African Meningococcal Carriage Consortium, MenAfriCar
.Hear the discussion